Voltammetric, spectrophotometric, and high performance liquid chromatographic analysis of olanzapine

Analytical Letters

Volumn 36, Issue 11, 2003, Pages 2497-2513

  Biryol, I ^a   Erk, N ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cyclic voltammetry; Differential pulse voltammetry; First derivative spectrophotometry; High performance liquid chromatography; Olanzapine; Pharmaceutical dosage forms; Square wave voltammetry

Indexed keywords

ACETONITRILE; BUFFER; OLANZAPINE;

ACCURACY; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG OXIDATION; ELECTRODE; LIQUID CHROMATOGRAPHY; OSTERYOUNG SQUARE WAVE VOLTAMMETRY; PH; POTENTIOMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPECTROPHOTOMETRY;

EID: 0042387900     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1081/AL-120024338     Document Type: Article

References (23)

1. Goodman and Gilman's. The Pharmacological Basis of Therapeutics, Eds.; 9th Ed.; Hardman, J.G., Limbird, L.E., Eds.; The McGraw-Hill Companies: 1996.
2. Aravagari, M.; Ames, D.; Wirshing, W.C.; Marder, S.R. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high performance liquid chromatography with electrochemical detection. Ther. Drug Monit. 1997, 19, 307.
3. Catlow, J.T.; Barton, R.D.; Clemens, M.; Gillespie, T.A.; Goodwin, M.; Swanson, S.P. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J. Chrom. B: 1995, 668, 85.
4. Chiu, J.A.; Franklin, R.B. Analysis and pharmacokinetics of olanzapine (LY 170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection. J. Pharm. Biomed. Anal. 1996, 14, 609.
5. Kasper, S.C.; Mattiuz, E.L.; Swanson, S.P.; Chiu, J.A.; Johnson, J.T.; Garner, C.O. Deter-mination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B: Biomed. Appl. 1999, 726, 203.
6. Dusci, L.J.; Peter Hackett, L.; Fellows, L.M.; Ilett, K.F: Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. J. Chromatog. B: 2002, 773, 191.
7. Olesen, O.V.; Linnet, K. Determination of olanzapine in serum by high performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs. J. Chromatog. B: 1998, 714, 309.
8. Boulton, D.W.; Markowitz, J.S.; DeVane, C.L. A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine. J. Chromatog. B: 2001, 759, 319.
9. Raggi, M.A.; Casamenti, G.; Mandrioli, R.; Fanali, S.; Ronchi, D.D.; Volterra, V. Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection. Chromatographia 2000, 51, 562.
10. Berna, M.; Shugert, R.; Mullen, J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 1998, 33, 1003.
11. Berna, M.; Ackermann, B.; Ruterbories, K.; Glass, S. Determination of olanzapine in human blood by liquid chromatography/tandem mass spectrometry. J. Chromatog. B: 2002, 767, 163.
12. Murphy, A.T.; Lake, B.G.; Bernstein, J.R.; Franklin, R.B.; Gillespie, T.A. Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography mass spectrometry. J. Mass Spectrom. 1998, 33, 1237.
13. Bogusz, M.J.; Krueger, K.D.; Maier, R.D.; Erkwoh, R.; Tuchtenhagen, F. Monitoring of olanzapine in serum by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B: Biomed. Appl. 1999, 732, 257.
14. Pucci, V.; Raggi, M.; Kenndler, E. Separation of eleven central nervous system drugs by capillary zone electrophoresis. J. Chromatogr. B: Biomed. Appl. 1999, 728, 263.
15. Pucci, V.; Raggi, M.A.; Kenndler, E. Quality control of pharmaceutical formulations of neuroleptic drugs by capillary zone electrophoresis. J. Liq. Chrom. and Rel. Technol. 2000, 23, 25.
16. Raggi, M.A.; Casamenti, G.;Mandrioli, R.; Izzo, G.; Kenndler, E. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry, and linear voltammetry. J. Pharm. Biomed. Anal. 2000, 23, 973.
17. Ozaltin, N.; Determination of lansoprazol in pharmaceutical dosage forms by two different spectroscopic methods. J. Pharm. Biomed. Anal. 1999, 20, 599.
18. Wang, L.; Asgharnejad, M. Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form. J. Pharm. Biomed. Anal. 2000, 21, 1243.
19. Altinöz, S.; Dursun, Ö.Ö. Determination of nimesulide in pharmaceutical dosage forms by second order derivative UV spectrophotometry. J. Pharm. Biomed. Anal. 2000, 22, 175.
20. Süslü, I.; Altinöz, S. Two derivative spectrophotometric determinations of indapamide in pharmaceutical dosage forms. J. Pharm. Biomed. Anal. 2002, 30, 357.
21. Tatar, S.; Saǧlik, S. Comparison of UV- and second derivativespectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J. Pharm. Biomed. Anal. 2002, 30, 371.
22. Panderi, I.E. Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide. J. Pharm. Biomed. Anal. 1999, 21, 257.
23. El-Gindy, A.; El-Walily, A.F.M.; Bedair, M.F. First derivative spectrophotometric and LC determination of cefuroxime and cefadroxil in urine. J. Pharm. Biomed. Anal. 2000, 23, 341.